PointState Capital’s Teladoc Health TDOC Stock Holding History

PointState Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-30,000	Closed	-$4.99M	–	175
2021 Q2	$4.99M	Buy	30,000 +15,000	+100%	+$2.43M	0.09%	97
2021 Q1	$2.73M	Sell	15,000 -7,500	-33%	-$1.74M	0.05%	106
2020 Q4	$4.5M	Buy	22,500 +9,000	+67%	+$1.83M	0.08%	96
2020 Q3	$2.96M	Buy	13,500 +3,400	+34%	+$720K	0.08%	79
2020 Q2	$1.93M	Buy	10,100 +1,136	+13%	+$199K	0.06%	73
2020 Q1	$1.39M	Buy	+8,964	New	+$1.04M	0.07%	57

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

PointState Capital's TDOC Position: Q3 2021 in Review

PointState Capital sold out of Teladoc Health (TDOC) in Q3 2021, closing a stake of 30,000 shares — an estimated $4.99M sold.

PointState Capital first reported a position in TDOC in Q1 2020 and held it in 6 quarters. The position peaked at $4.99M in Q2 2021. 761 funds tracked by Wall St. Rank hold TDOC as of Q3 2021.

PointState Capital reported no remaining Teladoc Health position as of Q3 2021 after selling out during the quarter.
PointState Capital sold 30,000 Teladoc Health shares in Q3 2021, an estimated $4.99M.
PointState Capital first reported a position in Teladoc Health in Q1 2020 and held it in 6 quarters.
PointState Capital's Teladoc Health position peaked at $4.99M in Q2 2021.
761 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2021.

Based on PointState Capital's 13F filing for Q3 2021, filed 15 Nov 2021.